Cancer Communications
indexed by SCI
BMC

doi: 10.5732/cjc.011.10362
Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells
Qing-Qing Wang, Zhi-Yi Zhang, Jian-Yong Xiao, Chun Yi, Lin-Zi Li, Yan Huang, Jing-Ping Yun
State Key Laboratory of Oncology in South China; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong 510060, P. R. China. yunjp@mail.sysu.edu.cn
[Abstract] Nucleophosmin/B23 (NPM) is a universally expressed nucleolar phosphoprotein that participates in proliferation, apoptosis, ribosome assembly, and centrosome duplication; however, the role of NPM in cell cycle regulation is not well characterized. We investigated the mechanism by which NPM is involved in cell cycle regulation. NPM was knocked down using siRNA in HepG2 hepatoblastoma cells. NPM translocation following actinomycin D (ActD) treatment was investigated using immunofluorescent staining. Expression of NPM and other factors involved in cell cycle regulation was examined by Western blotting. Cell cycle distribution was measured using flow cytometry to detect 5-ethynyl-2’-deoxyuridine (EdU) incorporation. Cell proliferation was quantified by the MTT assay. Knockdown of NPM increased the percentage of HepG2 cells in S phase and led to decreased expression of P53 and P21Cip1/WAF1. S-phase arrest in HepG2 cells was significantly enhanced by ActD treatment. Furthermore, knockdown of NPM abrogated ActD-induced G2/M phase cell cycle arrest. Taken together, these data demonstrate that inhibition of NPM has a significant effect on the cell cycle.
Chinese Journal of Cancer 2011, Volume: 30, Issue 12, Page: 853-860
[ PDF Full-text ]
[ PubMed ]

[Google Scholar]


Cite this article

Qing-Qing Wang, Zhi-Yi Zhang, Jian-Yong Xiao, Chun Yi, Lin-Zi Li, Yan Huang, Jing-Ping Yun. Knockdown of nucleophosmin induces S-phase arrest in HepG2 cells. Chin J Cancer. 2011, 30(12):853-860. doi:10.5732/cjc.011.10362


Export citations

EndNote


SHARE THIS ARTICLE


Your Comments

  

 


Comments:


CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China